About Wen Wang

Worked in Cell Therapy area for about 15 years. And very proud that I am the key contributor of early Clinical Development of Chinese 1st innovative CAR T-cell therapy new drug, Relma-cel. Also I am the project leader of CT103A, candidate of Chinese 1st BCMA-targeting CAR T-cell therapy drug. Experienced Chief Medical Officer with a demonstrated history of working in the biotechnology industry. Skilled in Cell Culture, Life Sciences, Confocal Microscopy, Science, and Western Blotting. Strong healthcare services professional with a Postdoctoral Research Fellow focused in Regenerative Medicine from The University of Connecticut Health Center.